Human Longevity, Inc. is a

San Diego San Diego ( , ) is a city on the Pacific coast of Southern California, adjacent to the Mexico–United States border. With a population of over 1.4 million, it is the List of United States cities by population, eighth-most populous city in t ...

–based venture launched by

Craig Venter John Craig Venter (born October 14, 1946) is an American scientist. He is known for leading one of the first draft sequences of the human genome and led the first team to transfect a cell with a synthetic chromosome. Venter founded Celera Geno ...

, Robert Hariri and

Peter Diamandis Peter H. Diamandis ( ; born May 20, 1961) is an American engineer, physician, and entrepreneur. He is best known as the founder and chairman of the XPRIZE Foundation, and the cofounder and executive chairman of Singularity University. He is ...

in 2013. Its goal is to build the world's most comprehensive database on human genotypes and phenotypes, and then subject it to machine learning so that it can help develop new ways to fight diseases associated with aging. The company received in investments in its Series A offering in summer 2014 and announced a further $220 million

Series B A venture round is a type of funding round used for venture capital financing, by which startup companies obtain investment, generally from venture capitalists and other institutional investors. The availability of venture funding is among the ...

investment offering in April 2016. It has made deals with drug companies

Celgene Celgene Corporation, headquartered in Summit, New Jersey, was a pharmaceutical company that produced cancer and immunology drugs. Its primary products were Revlimid (lenalidomide), which is used in the treatment of multiple myeloma (63% of 2018 r ...

and

AstraZeneca AstraZeneca plc () (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas includi ...

to collaborate in its research.

Overview

While it is conducting research, the company is offering a wellness service known as "Health Nucleus," which offers customers a range of medical tests such as a full genome sequencing and tests for early indications of

cancer Cancer is a group of diseases involving Cell growth#Disorders, abnormal cell growth with the potential to Invasion (cancer), invade or Metastasis, spread to other parts of the body. These contrast with benign tumors, which do not spread. Po ...

Alzheimer's Alzheimer's disease (AD) is a neurodegenerative disease and the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events. As the disease advances, symptoms can include problems wit ...

and

heart disease Cardiovascular disease (CVD) is any disease involving the heart or blood vessels. CVDs constitute a class of diseases that includes: coronary artery diseases (e.g. angina pectoris, angina, myocardial infarction, heart attack), heart failure, ...

. This testing is meant to help people catch diseases earlier than otherwise possible and to identify risk factors for diseases later in life. At the start of 2017, the company hired Cynthia Collins from GE Healthcare, and Venter became Executive Chair. The company's chief operating officer, Mark Winham, left the company in mid-2017, and Collins and the company's chief medical officer, Brad Perkins, left in December. Venter stepped back into the

CEO A chief executive officer (CEO), also known as a chief executive or managing director, is the top-ranking corporate officer charged with the management of an organization, usually a company or a nonprofit organization. CEOs find roles in variou ...

role, but announced in May 2018 that he was leaving the company to return to the J. Craig Venter Institute. Venter was sued for allegedly 'stealing trade secrets' at Human Longevity. The case has been dismissed. In November 2019, Human Longevity closed $30 million financing from Emerging Technology Partners (ETP) and other leading healthcare investors to renew its commitment to longevity and precision health. In November 2019, C. Thomas Caskey, professor of molecular & human genetics at the

Baylor College of Medicine The Baylor College of Medicine (BCM) is a private medical school in Houston, Texas, United States. Originally as the Baylor University College of Medicine from 1903 to 1969, the college became independent with the current name and has been se ...

, joined the company as Chief Medical Officer. In January 2020, Human Longevity published a study in the journal Proceedings of the National Academy of Sciences (PNAS) that showed that by integrating whole-genome sequencing with advanced imaging and blood metabolites, clinicians identified adults at risk for key health conditions. In June 2020, Human Longevity launched a proprietary program called 100+ longevity program. The program claims to combine the most advanced technologies with a dedicated medical team to help people achieve their healthiest and longest life. In June 2022, Human Longevity announced an

initial public offering An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors and usually also to retail (individual) investors. An IPO is typically underwritten by one or more investm ...

through a

SPAC SPAC primarily refers to a special-purpose acquisition company, a method of taking a company public by merging it with an already public investment company. SPAC may also refer to: * Henry Crown Sports and Aquatics Center, a sports facility at No ...

, with a valuation of $1 billion.

References

External links

* {{authority control Genetics organizations Human genome projects Biogerontology organizations Life extension organizations Biotechnology companies of the United States 2013 establishments in California

Overview

See also

References

External links